Literature DB >> 7948819

Effects of an infusion of branched-chain amino acids on neurophysiological and psychometric testings in cirrhotic patients with mild hepatic encephalopathy.

K Higuchi1, Y Shimizu, S Nambu, C Miyabayashi, T Takahara, S Saito, O Hioki, Y Kuwabara, A Watanabe.   

Abstract

Psychotropic action of a branched-chain-enriched amino acid solution (Aminoleban) was quantitatively and visually examined in six cirrhotic patients with mild hepatic encephalopathy (grades I and II) using electrophysiological and psychometric methods. Neurophysiological effects of the amino acid solution were observed by comparing topographic spectrum analyses of electroencephalography (EEG) before and immediately after an intravenous 3 h infusion of the solution. The delta wave in the frontal region diminished from 61 +/- 13 to 12 +/- 4% (P < 0.01) and the alpha wave in the occipital region increased from 11 +/- 3 to 51 +/- 11% (P < 0.01). Latencies of the P3 wave in visual evoked potentials, which were topographically recorded in the occipital region, shortened from 220 +/- 32 to 148 +/- 19 ms (P < 0.01). Latencies of the P300 wave in event-related potentials, which were topographically recorded in the centro-temporal region, shortened from 493 +/- 81 to 360 +/- 93 ms (P < 0.05). Topographic reaction pattern of P300 was irregular toward the occipital or parietal region in cirrhotic patients. The EEG frequency power spectrum, illustrated by the colour density spectral array of computer-aided polysomnography analysis, clearly showed a gradual increase of the alpha wave spectrum and a gradual decrease of the delta wave spectrum after initiation of the infusion. These immediate neurophysiological changes were confirmed by improvement of quantitative psychometric tests including number connection test, reaction time to sound, and digit symbol and block design tests of Wechsler Adult Intelligence Scale.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948819     DOI: 10.1111/j.1440-1746.1994.tb01257.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability.

Authors:  A Watanabe; T Tuchida; Y Yata; Y Kuwabara
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

2.  Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.

Authors:  H Miyaji; S Ito; T Azuma; Y Ito; Y Yamazaki; Y Ohtaki; F Sato; M Hirai; M Kuriyama; Y Kohli
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

Review 3.  Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach.

Authors:  Sara Montagnese; Piero Amodio; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

4.  Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.

Authors:  Josef Finsterer; Elisabeth Bernauer
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

5.  Evaluation of cingulate gyrus blood flow in patients with liver cirrhosis.

Authors:  Motoh Iwasa; Kaname Matsumura; Yuri Nakagawa; Mika Yamamoto; Hideaki Tanaka; Shinichiro Horiike; Jiro Ikoma; Masahiko Kaito; Kan Takeda; Yukihiko Adachi
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.